Literature DB >> 24286950

Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Ankur Jindal1, Mariana Garcia-Touza, Nidhi Jindal, Adam Whaley-Connell, James R Sowers.   

Abstract

In this article, the literature is reviewed regarding the role of blood pressure variability and nocturnal nondipping of blood pressure as well as the presence of diabetic kidney disease (DKD), in the absence of albuminuria, as risk predictors for progressive DKD. The importance of glycemic and blood pressure control in patients with diabetes and chronic kidney disease, and the use of oral hypoglycemic agents and antihypertensive agents in this patient cohort, are also discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albuminuria; Blood pressure variability; Cardiorenal syndrome; Chronic kidney disease; Diabetes; Diabetic nephropathy; Proteinuria

Mesh：

Substances：

Year:  2013        PMID： 24286950      PMCID： PMC4251585          DOI： 10.1016/j.ecl.2013.06.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  89 in total

Review 1.  Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis.

Authors:  Christopher E Clark; Rod S Taylor; Angela C Shore; Obioha C Ukoumunne; John L Campbell
Journal:  Lancet       Date:  2012-01-30       Impact factor: 79.321

2.  Clinical significance of nonalbuminuric renal impairment in type 2 diabetes.

Authors:  Giuseppe Penno; Anna Solini; Enzo Bonora; Cecilia Fondelli; Emanuela Orsi; Gianpaolo Zerbini; Roberto Trevisan; Monica Vedovato; Gabriella Gruden; Franco Cavalot; Mauro Cignarelli; Luigi Laviola; Susanna Morano; Antonio Nicolucci; Giuseppe Pugliese
Journal:  J Hypertens       Date:  2011-09       Impact factor: 4.844

3.  Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors.

Authors:  Ankur Jindal; Stephen Brietzke; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-24       Impact factor: 2.041

4.  Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.

Authors:  M A Gall; P Hougaard; K Borch-Johnsen; H H Parving
Journal:  BMJ       Date:  1997-03-15

5.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

6.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

7.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

8.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

9.  National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.

Authors:  George Bakris; Joseph Vassalotti; Eberhard Ritz; Christoph Wanner; George Stergiou; Mark Molitch; Richard Nesto; George A Kaysen; James R Sowers
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

10.  Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Authors:  Jean M Whaley; Mark Tirmenstein; Timothy P Reilly; Simon M Poucher; Joanne Saye; Shamik Parikh; James F List
Journal:  Diabetes Metab Syndr Obes       Date:  2012-07-23       Impact factor: 3.168
View more
  16 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

2.  Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Authors:  Jefferson C Frisbee; Matthew T Lewis; Jonathan D Kasper; Paul D Chantler; Robert W Wiseman
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

Review 3.  Fructose and uric acid: is there a role in endothelial function?

Authors:  Guanghong Jia; Annayya R Aroor; Adam T Whaley-Connell; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

4.  Fructose induces prothrombotic phenotype in human endothelial cells : A new role for "added sugar" in cardio-metabolic risk.

Authors:  Plinio Cirillo; Grazia Pellegrino; Stefano Conte; Fabio Maresca; Francesco Pacifico; Antonio Leonardi; Bruno Trimarco
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

Review 5.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

6.  Myocardial infarction worsens glomerular injury and microalbuminuria in rats with pre-existing renal impairment accompanied by the activation of ER stress and inflammation.

Authors:  Zhifeng Dong; Penglong Wu; Yongguang Li; Yuan Shen; Ping Xin; Shuai Li; Zhihua Wang; Xiaoyan Dai; Wei Zhu; Meng Wei
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

Review 7.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 8.  Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology.

Authors:  Matthew J Budoff; Paolo Raggi; George A Beller; Daniel S Berman; Regina S Druz; Shaista Malik; Vera H Rigolin; Wm Guy Weigold; Prem Soman
Journal:  JACC Cardiovasc Imaging       Date:  2016-02

Review 9.  Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes.

Authors:  Dimitrios G Chatzis; Konstantinos Kolokathis; Kalliopi Magounaki; Stefanos Chatzidakis; Konstantinos Avramidis; Marianna Leopoulou; Theodoros P Angelopoulos; John Doupis
Journal:  touchREV Endocrinol       Date:  2021-11-17

10.  Perioperative management of diabetic foot.

Authors:  Nune Soghomonyan
Journal:  Front Pharmacol       Date:  2014-05-01       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.